Abstract
Adequate adrenal function is fundamental to survive critical illness. Cortisol is vital in the host adaptation to stress. It is essential to maintain the normal vascular tone, endothelial integrity, vascular permeability, and the distribution of total body water within the vascular compartment (1–5). Consequently, the failure of an appropriate adrenal response in the setting of critical illness, an abnormality known as relative or functional adrenal insufficiency (RAI), may have important clinical consequences.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schuetz P, Müller B. The hypothalamic-pituitary-adrenal axis in critical illness. In: Acute Endocrinology. Endocrinol Metab Clin North Am 2006;35:823–38.
Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727–34.
Widmer IE, Puder JJ, König C, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005;90:4579–86.
Reincke M, Allolio B, Wurth G, et al. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:151–6.
Jurney TH, Cockrell Jr. JL, Lindberg JS, et al. Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest 1987;92:292–5.
Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038–45.
Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862–71.
Beishuizen A, Thijs LG. Relative adrenal insufficiency in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001;15:513–31.
Briegel J, Schelling G, Haller M, et al. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996;22:894–9.
Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337:582–3.
Sibbald WJ, Short A, Cohen MP, et al. Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977;186:29–33.
Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995;98:266–71.
Bollaert PE, Fieux F, Charpentier C, et al. Baseline cortisol levels, cortisol response to corticotropin, and prognosis in late septic shock. Shock 2003;19:13–5.
Annane D, Bellissant E, Sebille V, et al. Impaired pressor sensitivity to norepinephrine in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998;46:591–9.
Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004;350:1629–38.
Perrot D, Bonneton A, Dechaud H, et al. Hypercortisolism in septic shock is not suppressible by dexamethasone infusion. Crit Care Med 1993;21:396–401.
Langouche L, Van den Berghe G. The dynamic neuroendocrine response to critical illness. In: Acute Endocrinology. Endocrinol Metab Clin North Am 2006;35:777–91.
Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33:2457–64.
Annane D, Cavaillon JM. Corticosteroid in sepsis: from bench to bedside? Shock 2003;20:197–207.
Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of low dose hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003;167:512–20.
Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990;87:10043–7.
Grinspoon SK, Biller B. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994;79:923–31.
Sprung CL, Annane D, Keh D, et al. for the CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111–24.
Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296–327.
Marik PE, Pastores SM, Annane D, et al. for the American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937–49.
Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effects of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004;141:47–56.
Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723–32.
Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645–50.
Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Br Med J 2004;329:480–9.
Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006;43:673–81.
Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 2003;23:71–7.
Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005;33:1254–9.
Fernandez J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006;44:1288–95.
Thierry S, Giroux Leprieur E, Lecuyer L, et al. Echocardiographic features, mortality and adrenal function in patients with cirrhosis and septic shock. Acta Anaesthesiol Scand 2008;52:45–51.
Cheyron D, Bouchet B, Cauquelin B, et al. Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis. Intensive Care Med 2008;34:116–24.
Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227–32.
Guevara M, Bru C, Gines P, et al. Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology 1998;28:39–44.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fernández, J., Acevedo, J. (2011). Adrenal Function in Chronic Liver Failure. In: Ginès, P., Kamath, P., Arroyo, V. (eds) Chronic Liver Failure. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-866-9_19
Download citation
DOI: https://doi.org/10.1007/978-1-60761-866-9_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-865-2
Online ISBN: 978-1-60761-866-9
eBook Packages: MedicineMedicine (R0)